Related Experiment Video
Updated: Nov 3, 2025

Intravital Imaging of Axonal Interactions with Microglia and Macrophages in a Mouse Dorsal Column Crush Injury
Published on: November 23, 2014
Microglia: A Potential Drug Target for Traumatic Axonal Injury
Xin Huang1, Wendong You2, Yuanrun Zhu2
1Department of Neurosurgery, First Affiliated Hospital, Zhejiang University School of Medicine, China.
Abstract:
Traumatic axonal injury (TAI) is a major cause of death and disability among patients with severe traumatic brain injury (TBI); however, no effective therapies have been developed to treat this disorder. Neuroinflammation accompanying microglial activation after TBI is likely to be an important factor in TAI. In this review, we summarize the current research in this field, and recent studies suggest that microglial activation plays an important role in TAI development. We discuss several drugs and therapies that may aid TAI recovery by modulating the microglial phenotype following TBI. Based on the findings of recent studies, we conclude that the promotion of active microglia to the M2 phenotype is a potential drug target for the treatment of TAI.
Insights
Traumatic axonal injury (TAI) following brain injury is a major cause of death. Promoting M2-phenotype microglia may offer a new therapeutic strategy for TAI recovery.
Area of Science:
- Neuroscience
- Traumatic Brain Injury Research
- Neuroinflammation
Background:
- Traumatic axonal injury (TAI) is a significant cause of mortality and disability in severe traumatic brain injury (TBI).
- Neuroinflammation, particularly microglial activation, is implicated in TAI pathogenesis.
- Current therapeutic options for TAI remain limited.
Purpose of the Study:
- To review current research on the role of microglial activation in TAI.
- To explore potential therapeutic strategies targeting microglial modulation for TAI recovery.
Main Methods:
- Literature review of recent studies on TAI and microglial activation.
- Analysis of therapeutic approaches aimed at modulating microglial phenotype post-TBI.
Main Results:
- Recent studies indicate a critical role for microglial activation in the development of TAI.
- Modulating microglial phenotype shows promise for aiding TAI recovery.
Conclusions:
- Microglial activation is a key factor in TAI development after TBI.
- Shifting microglia towards the M2 phenotype represents a potential therapeutic target for TAI treatment.

